Navigation Links
Bayer CropScience Looks to the Future of Farming at 2013 Farm Progress Show
Date:8/29/2013

ence Blog:
http://connect.bayercropscience.us/

###
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company is celebrating 150 years of Bayer?consistent with its mission “Bayer: Science For A Better Life.” Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action, as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at http://www.press.bayercropscience.com.

Contact:
Bayer CropScience Media Hotline, 1-877-879-6162, or

Becca Hogan
External Communications
Bayer CropScience
Tel: (919) 549-2998
Email: becca(dot)hogan(at)bayer(dot)com

Jenell Loschke
Charleston|Orwig
Tel: (262) 957-6031
Email: jloschke(at)charlestonorwig(dot)com

BCS-2013-0245
Find more information, visit http://www.bayercropscience.us

Forward-Looking Statements
This release may contain forw
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
2. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
3. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
4. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
5. Bayer Bee Care Center Helps Solve Bee Health’s Toughest Challenges
6. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
7. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
8. Bayer CropScience Launches Third Annual Young Farmer Sustainability Award Program
9. Bayer CropScience Hosts Inaugural Vegetable Future Forum in Monheim
10. Bayer CropScience Announces Registration for use of Alion on Grapes in California
11. Bayer CropScience Purchases Land Adjacent to its Research Triangle Park Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... LONDON , July 29, 2015 ... on acquiring, rapidly developing and commercialising ... human health   Highly experienced management team; ...     Mereo BioPharma Group Ltd ... successfully raised $119m ( c. £76.5m), gross, from blue ...
(Date:7/28/2015)... Nev. , July 28, 2015  PDL BioPharma, ... today announced that the Company will release its second ... 30, 2015, on Wednesday, August 5, 2015, after market ... webcast that day at 4:30 p.m. Eastern Time to ... the call will be available via the webcast link ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... EUR 1.022 billion in 2013; while production volume reached close to 1.84 million ... country with a share of 75.5% of the region’s total aluminium hydroxide production; ...
(Date:7/28/2015)... Poway, CA (PRWEB) , ... July 28, 2015 , ... ... by a live stem cell credentialing course to local area veterinarians. , The tour ... RACE approved CE units at no charge) at VetStem’s Poway facility. Staff members are ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2
... Toronto Stock Exchange Symbol: MS, EDMONTON, Nov. 5 /PRNewswire-FirstCall/ ... treatment of multiple sclerosis (MS), today,announced that Mr. Kevin Giese, ... Annual Healthcare Conference in New York., WHEN: ... WHERE: New York Palace Hotel, New ...
... Therapeutics Inc., a privately,held biopharmaceutical company, announced ... Dr. John Dietrich have joined its Board ... commented: "It is a great,pleasure to welcome ... Board,where they will enhance our capabilities in ...
... 5 Dendreon Corporation (Nasdaq:,DNDN) today announced that management will ... & Renshaw 10th Annual Healthcare Conference New York Palace ... Lazard Capital Markets 5th Annual Healthcare Conference The ... 8:55 a.m. ET, The presentations will be audio ...
Cached Biology Technology:BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference 2Trillium Strengthens its Board of Directors 2
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... now, the scientific community had thought that whistles were ... unaware of the importance and use of burst-pulsed sounds. ... in Sardinia (Italy) have now shown that these sounds ... their behaviour. , "Burst-pulsed sounds are used in the ...
... Patients in the early to moderate stages ... slowed or even reversed by switching to a ... In a previous study [ http://www.temple.edu/newsroom/2009_2010/12/stories/alzheimers.htm ], ... of pharmacology in Temple,s School of Medicine, demonstrated ...
... at Oregon State University have demonstrated for the first ... trees can be changed through "cisgenics" a type ... plant breeding. Cisgenics uses genes from closely related ... to regulate it similarly to conventional breeding, experts say, ...
Cached Biology News:Dolphins use diplomacy in their communication 2Healthy diet could slow or reverse early effects of Alzheimer's disease 2Success with 'cisgenics' in forestry offers new tools for biotechnology 2Success with 'cisgenics' in forestry offers new tools for biotechnology 3
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: